MYELOID LEUKEMIA, PHILADELPHIA POSITIVE

Clinical trials for MYELOID LEUKEMIA, PHILADELPHIA POSITIVE explained in plain language.

Never miss a new study

Get alerted when new MYELOID LEUKEMIA, PHILADELPHIA POSITIVE trials appear

Sign up with your email to follow new studies for MYELOID LEUKEMIA, PHILADELPHIA POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for kids with Tough-to-Treat leukemia

Disease control Recruiting now

This study is testing a medicine called asciminib in children and teenagers (ages 1 to 18) with a specific type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia. The main goal is to find the right dose for kids and check its safety, especially for …

Matched conditions: MYELOID LEUKEMIA, PHILADELPHIA POSITIVE

Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 02, 2026 15:21 UTC

MYELOID LEUKEMIA, PHILADELPHIA POSITIVE

Get alerted when new MYELOID LEUKEMIA, PHILADELPHIA POSITIVE trials appear

New hope for kids with Tough-to-Treat leukemia